Indapamida Gp (Indapamide)

Indapamide blocks the sodium‑chloride symporter in the distal convoluted tubule of the kidney. By inhibiting reabsorption of sodium and chloride, it increases urinary excretion of these ions together with water, lowering plasma volume and peripheral vascular resistance, which reduces blood pressure and edema.

The specific dose of Indapamida Gp is determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and renal function. Dosage adjustments are individualized, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

The safety of indapamide in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class, which primarily reduces blood volume and peripheral resistance. Compared with ACE inhibitors or calcium‑channel blockers, it may be less potent for certain patients but offers a useful combination option, especially when fluid overload is also present. Choice of therapy depends on individual patient profiles and comorbidities.

Indapamida Gp should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Indapamida Gp is taken orally, usually with a glass of water. It may be administered with or without food, but patients should follow the prescriber’s guidance regarding timing and whether to take it in the morning or evening to minimise nocturnal diuresis.

Serious risks include severe dehydration, marked electrolyte disturbances such as hyponatremia or hypokalemia, and rare allergic reactions like angioedema. Patients should be monitored for signs of dizziness, fainting, muscle cramps, or unusual skin reactions, and seek medical attention promptly if these occur.

Indapamida Gp is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide derivatives, severe renal impairment, and in individuals with anuria. Caution is also advised for patients with gout, hepatic disease, or those taking interacting medications such as lithium or NSAIDs.